Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Cash from Operating Activities
Shandong Pharmaceutical Glass Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cash from Operating Activities
¥780.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash from Operating Activities
¥2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cash from Operating Activities
¥3B
|
CAGR 3-Years
71%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash from Operating Activities
¥1.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Cash from Operating Activities
¥723.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
780.7m
CNY
Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Cash from Operating Activities amounts to 780.7m CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
17%
Over the last year, the Cash from Operating Activities growth was 42%. The average annual Cash from Operating Activities growth rates for Shandong Pharmaceutical Glass Co Ltd have been 16% over the past three years , 10% over the past five years , and 17% over the past ten years .